Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care
Journal of Clinical Pathology Aug 31, 2017
Conroy S, et al. – Researchers in this study aspired to assess the yield of inflammatory bowel disease (IBD) from faecal calprotectin (FC) testing in primary care. For diagnosing IBD, FC testing in primary care had low sensitivity and specificity with poor positive predictive value (PPV). Moreover, they advised directing its use to those with a higher pretest probability of disease.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
